Ładuje się......
A robust prognostic gene expression signature for early stage lung adenocarcinoma
BACKGROUND: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients would be critical to identify those most likely to benefit from early addition...
Zapisane w:
| Wydane w: | Biomark Res |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761211/ https://ncbi.nlm.nih.gov/pubmed/26900477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-016-0058-3 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|